Salix Pharms., Ltd. v. Norwich Pharms. Inc. : United States Court of Appeals of the Federal Circuit, 202498 F.4th 1056

被引：0

作者：

Holman, Christopher M. ^{[1
,2
]}

机构：

[1] Univ Missouri, Sch Law, Law, Kansas City, MO 64110 USA

[2] George Mason Univ, Ctr Protect Intellectual Property, Antonin Scalia Law Sch, Fairfax, VA 22030 USA

来源：

BIOTECHNOLOGY LAW REPORT | 2024年 / 43卷 / 04期

关键词：

D O I：

10.1089/blr.2024.56589.spn

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：232 / 241

页数：10

共 50 条

[1] Regeneron Pharms., Inc. v. Mylan Pharms. Inc.: United States Court of Appeals of the Federal Circuit, 2025 127 F.4th 896
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2025,
[2] Actelion Pharms. LTD v. Mylan Pharms. Inc.
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2024, 43 (01) : 42 - 46
[3] AstraZeneca AB v. Mylan Pharms. Inc. United States Court of Appeals of the Federal Circuit, 202119 F.4th 1325
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2022, 41 (02)
[4] Amarin Pharma, Inc. v. Hikma Pharms. USA, Inc.: United States Court of Appeals of the Federal Circuit, 2024 104 F.4th 1370
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2024, 43 (04) : 224 - 231
[5] Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.: United States Court of Appeals of the Federal Circuit, 2024 104 F.4th 1370
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2024,
[6] Novartis Pharms. Corp. v. Accord Healthcare, Inc. United States Court of Appeals of the Federal Circuit, 2022 21 F.4th 1362
HOLMAN, C. H. R. I. S. T. O. P. H. E. R. M. M.
BIOTECHNOLOGY LAW REPORT, 2022, 41 (02) : 106 - 117
[7] Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc. United States Court of Appeals of the Federal Circuit, 2023 66 F.4th 1373
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2023, 42 (05) : 264 - 269
[8] Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147
Holman, Christopher M. M.
BIOTECHNOLOGY LAW REPORT, 2022, 41 (06) : 305 - 310
[9] Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC United States Court of Appeals of the Federal Circuit, 2023 No. 2023-1186, 2023 WL 2198640
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2023, 42 (02) : 102 - 107
[10] Par Pharm., Inc. v. Eagle Pharms., Inc. United States Court of Appeals of the Federal Circuit, 2022 No. 2021-2342, 2022 WL 3449817
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2022, 41 (05) : 258 - 261

← 1 2 3 4 5 →